Pembrokeshire
Medical
Full Cancer Genetic Screen
Gain comprehensive insights into your hereditary cancer risk with our Full Cancer Genetic Screen. This advanced test analyses 94 genes linked to increased risk for breast, ovarian, prostate, colorectal, and thyroid cancers. Empower yourself with knowledge for personalised prevention and early detection strategies. Available at our Pembrokeshire clinic
Cost: £899
Why consider genetic testing?
Understanding your genetic predispositions is a powerful step in proactive health management, especially when it comes to cancer risk. Our Full Cancer Genetic Screen offers an unparalleled level of insight, analysing a broad spectrum of genes associated with an increased inherited risk of various cancers.
This advanced genetic test is designed to provide a comprehensive risk assessment by performing screening for mutations in 94 genes linked to hereditary cancer syndromes. This extensive panel covers genes associated with an increased risk for:
-
Breast Cancer
-
Ovarian Cancer
-
Prostate Cancer
-
Colorectal (Bowel) Cancer
-
Thyroid Cancer
-
...and many other related cancer types.
Our comprehensive gene panel includes:
AIP, ALK, APC, ATM, BAP1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CDC73, CDH1, CDK4, CDKN1C, CDKN2A, CEBPA, CEP57, CHEK2, CYLD, DDB2, DICER1, DIS3L2, EGFR, EPCAM, ERCC2, ERCC3, ERCC4, ERCC5, EXT1, EXT2, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GATA2, GPC3, HNF1A, HRAS, KIT, MAX, MEN1, MET, MLH1, MSH2, MSH6, MUTYH, NBN, NF1, NF2, NSD1, PALB2, PHOX2B, PMS1, PMS2, PRF1, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RECQL4, RET, RHBDF2, RUNX1, SBDS, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCB1, STK11, SUFU, TMEM127, TP53, TSC1, TSC2, VHL, WRN, WT1, XPA, XPC.